Template:Cryptococcus Meningitis: Difference between revisions
(Convert to AntibioticDose with disease=Cryptococcosis for SMW linking) |
(Add pediatric cryptococcal meningitis dosing) |
||
| Line 7: | Line 7: | ||
**Followed by {{AntibioticDose|disease=Cryptococcosis|drug=Fluconazole|dose=400mg PO q24hrs x 8 weeks|context=Meningitis consolidation with AIDS|population=Adult}} | **Followed by {{AntibioticDose|disease=Cryptococcosis|drug=Fluconazole|dose=400mg PO q24hrs x 8 weeks|context=Meningitis consolidation with AIDS|population=Adult}} | ||
*Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome | *Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome | ||
===Pediatric Cryptococcal Meningitis=== | |||
*{{AntibioticDose|disease=Cryptococcosis|drug=Amphotericin B|dose=0.7-1mg/kg IV daily x 2-4 weeks|context=Pediatric Meningitis|population=Pediatric}} + Flucytosine 25mg/kg PO q6hrs | |||
**Followed by {{AntibioticDose|disease=Cryptococcosis|drug=Fluconazole|dose=6-12mg/kg PO daily x 8 weeks (max 400mg)|context=Pediatric Consolidation|population=Pediatric}} | |||
Latest revision as of 13:21, 20 March 2026
Meningitis (not AIDs associated)
- Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 4 weeks
- Followed by Fluconazole 400mg PO q24hrs x 8 weeks
Meningitis (with AIDS)
- Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 2 weeks
- Followed by Fluconazole 400mg PO q24hrs x 8 weeks
- Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome
Pediatric Cryptococcal Meningitis
- Amphotericin B 0.7-1mg/kg IV daily x 2-4 weeks + Flucytosine 25mg/kg PO q6hrs
- Followed by Fluconazole 6-12mg/kg PO daily x 8 weeks (max 400mg)